A study published in The Lancet Infectious Diseases medical journal shows that the vaccine 'induced higher neutralising antibody responses than those observed in adults'.
Citing good manufacturing practices deficiencies, the World Health Organization (WHO) on April 2 confirmed the suspension of supply of Covaxin
Serious adverse events following immunisation are between 10 to 15 per million population, Rai said. "So, if you do the risk and benefit analysis in adults, it is a huge benefit," he said.
FDA had earlier implemented a temporary pause on Covaxin trials, following the WHO's observations on Covaxin manufacturing plants in India.
The WHO asked countries that have received the vaccine to take appropriate actions, according to the statement, but did not specify what the appropriate actions would be
The decision has come after Brazil suspended Covaxin’s proposed clinical trials and a request for Emergency Use Authorisation.
The study by the ICMR and Covaxin manufacturer Bharat Biotech was conducted in January and the findings were published in the Journal of Travel Medicine on March 24.
Santosh K More has raised the issue in a tweet tagging PM Modi and Serum Institute CEO Adar Poonawalla
Ocugen in a statement on Thursday announced that as recommended by the FDA, it will pursue submission of a biologics license application (BLA) for Covaxin.
The Delhi Disaster Management Authority has asked senior officials of health and revenue departments and district magistrates to ensure compliance to the order...
The trials are commencing after the Drugs Controller General of India’s (DCGI) nod for the Phase 2 and 3 clinical trials of Covaxin on children.
Covid explained: The trial will be conducted on 525 healthy volunteers at different sites across the country. These sites are expected to include AIIMS, Delhi...
The trial involves two vaccine doses injected on day 0 and day 28.
The trial will take place in 525 subjects at various sites, including AIIMS, Delhi, AIIMS, Patna and Meditrina Institute of Medical Sciences, Nagpur.
Bharat Biotech has also claimed that according to second interim data gained from Phase III analysis, chances of Covid-19 infection reduced by 100 per cent...
Chhattisgarh Health Minister T S Singh Deo said he had written to Harsh Vardhan urging him not to send Bharat Biotech's Covaxin till the phase-3 clinical trial...
.jpg)
Medical experts have advised volunteers who have participated in Phase III clinical trials of Covaxin to use a condom for sex for three months.
The clinical efficacy of the vaccine is yet to be established and it is still being studied in phase 3 clinical trials.
The clinical efficacy of the vaccine is yet to be established and it is still being studied in phase 3 clinical trials.
Family members of Deepak Marawi claim that he and his colleague were administered the Covaxin injection on December 12 during the trial.
Bharat Biotech had said it is the only Phase-3 efficacy study for a COVID-19 vaccine, and the largest efficacy trial (Phase-3) ever conducted for any vaccine...
'Our goal is to provide global access to populations that need it the most,' founder Krishna Ella said
Govt proposes another meeting on December 9; seeks time from unions to present a concrete proposal
Chief of Neurosciences Centre at AIIMS, and three other volunteers receive the first dose.
Anil Vij becomes the first cabinet minister to volunteer for a potential vaccine against Covid-19.
